$SFCC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PharmaNet Development Group Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PharmaNet Development Group Inc. Get notifications about new insider transactions in PharmaNet Development Group Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 24 2009 | SFCC | PharmaNet Developm ... | OLIVIER DAVID M | Director | Sell | U | 5.00 | 14,998 | 74,990 | 0 | 15 K to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Sheldrick Robin Cashen | Senior VP, Human Re ... | Option Exercise | D | 29.47 | 1,254 | 36,955 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Sheldrick Robin Cashen | Senior VP, Human Re ... | Option Exercise | D | 26.91 | 1,218 | 32,776 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Sheldrick Robin Cashen | Senior VP, Human Re ... | Option Exercise | D | 13.86 | 3,571 | 49,494 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Sheldrick Robin Cashen | Senior VP, Human Re ... | Option Exercise | D | 40.39 | 2,626 | 106,064 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Sheldrick Robin Cashen | Senior VP, Human Re ... | Buy | U | 5.00 | 16,612 | 83,060 | 0 | -16,612 to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | WOLD OLSEN PER | Director | Sell | U | 5.00 | 19,998 | 99,990 | 0 | 20 K to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir. | Option Exercise | D | 29.47 | 16,701 | 492,178 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir. | Option Exercise | D | 26.91 | 16,155 | 434,731 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir. | Option Exercise | D | 38.00 | 24,593 | 934,534 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir. | Option Exercise | D | 40.39 | 103,800 | 4,192,482 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir. | Sell | U | 5.00 | 143,651 | 718,255 | 0 | 143.7 K to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Sell | U | 5.00 | 20,424 | 102,120 | 0 | 20.4 K to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Di Ianni Mark | EVP | Option Exercise | D | 29.47 | 4,694 | 138,332 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Di Ianni Mark | EVP | Option Exercise | D | 26.91 | 4,649 | 125,105 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Di Ianni Mark | EVP | Sell | U | 5.00 | 19,315 | 96,575 | 0 | 19.3 K to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | CLASSON ROLF A | Director | Sell | U | 5.00 | 16,502 | 82,510 | 0 | 16.5 K to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | TOMBROS PETER G | Director | Sell | U | 5.00 | 21,377 | 106,885 | 0 | 21.4 K to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Sell | U | 5.00 | 800 | 4,000 | 0 | 800 to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Sell | U | 5.00 | 25,971 | 129,855 | 0 | 26 K to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Hamill John P | EVP and CFO | Option Exercise | D | 29.47 | 4,841 | 142,664 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Hamill John P | EVP and CFO | Option Exercise | D | 26.91 | 4,533 | 121,983 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Hamill John P | EVP and CFO | Option Exercise | D | 13.86 | 3,571 | 49,494 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Hamill John P | EVP and CFO | Option Exercise | D | 40.39 | 895 | 36,149 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Hamill John P | EVP and CFO | Sell | U | 5.00 | 45,396 | 226,980 | 0 | 45.4 K to 0 (-100.00 %) |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Option Exercise | D | 29.47 | 6,020 | 177,409 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Option Exercise | D | 26.91 | 5,742 | 154,517 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Option Exercise | D | 15.82 | 10,000 | 158,200 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Option Exercise | D | 13.86 | 3,571 | 49,494 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Option Exercise | D | 40.39 | 14,305 | 577,779 | 0 | |
Mar 24 2009 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Sell | U | 5.00 | 54,463 | 272,315 | 0 | 54.5 K to 0 (-100.00 %) |
Jun 06 2008 | SFCC | PharmaNet Developm ... | OLIVIER DAVID M | Director | Grant | A | 16.33 | 7,654 | 124,990 | 14,998 | 7.3 K to 15 K (+104.22 %) |
Jun 06 2008 | SFCC | PharmaNet Developm ... | CLASSON ROLF A | Director | Grant | A | 16.33 | 7,654 | 124,990 | 16,502 | 8.8 K to 16.5 K (+86.51 %) |
Jun 06 2008 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Grant | A | 16.33 | 7,654 | 124,990 | 20,424 | 12.8 K to 20.4 K (+59.94 %) |
Jun 06 2008 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Grant | A | 16.33 | 7,654 | 124,990 | 25,971 | 18.3 K to 26 K (+41.79 %) |
Jun 06 2008 | SFCC | PharmaNet Developm ... | TOMBROS PETER G | Director | Grant | A | 16.33 | 11,481 | 187,485 | 21,377 | 9.9 K to 21.4 K (+116.02 %) |
Jun 06 2008 | SFCC | PharmaNet Developm ... | WOLD OLSEN PER | Director | Grant | A | 16.33 | 7,654 | 124,990 | 19,998 | 12.3 K to 20 K (+62.01 %) |
May 12 2008 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Buy | P | 13.89 | 2,000 | 27,780 | 12,770 | 10.8 K to 12.8 K (+18.57 %) |
May 05 2008 | SFCC | PharmaNet Developm ... | Hamill John P | EVP and CFO | Buy | P | 14.82 | 500 | 7,410 | 45,299 | 44.8 K to 45.3 K (+1.12 %) |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Boucher-Champagne Johane | Option Exercise | A | 29.47 | 847 | 24,961 | 1,714 | ||
Mar 06 2008 | SFCC | PharmaNet Developm ... | Boucher-Champagne Johane | Option Exercise | A | 29.47 | 1,689 | 49,775 | 40,816 | ||
Mar 06 2008 | SFCC | PharmaNet Developm ... | Boucher-Champagne Johane | Grant | A | 29.47 | 847 | 24,961 | 11,890 | 11 K to 11.9 K (+7.67 %) | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Option Exercise | A | 29.47 | 3,017 | 88,911 | 6,077 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Option Exercise | A | 29.47 | 6,020 | 177,409 | 39,638 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Grant | A | 29.47 | 13,017 | 383,611 | 53,367 | 40.4 K to 53.4 K (+32.26 %) |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Di Ianni Mark | EVP | Option Exercise | A | 29.47 | 2,353 | 69,343 | 4,830 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Di Ianni Mark | EVP | Option Exercise | A | 29.47 | 4,694 | 138,332 | 9,343 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Di Ianni Mark | EVP | Grant | A | 29.47 | 2,353 | 69,343 | 16,483 | 14.1 K to 16.5 K (+16.65 %) |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Hamill John P | EVP and CFO | Option Exercise | A | 29.47 | 2,426 | 71,494 | 29,841 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Hamill John P | EVP and CFO | Option Exercise | A | 29.47 | 4,841 | 142,664 | 13,840 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Hamill John P | EVP and CFO | Grant | A | 29.47 | 7,426 | 218,844 | 44,799 | 37.4 K to 44.8 K (+19.87 %) |
Mar 06 2008 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir | Option Exercise | A | 29.47 | 8,370 | 246,664 | 76,979 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir | Option Exercise | A | 29.47 | 16,701 | 492,178 | 161,249 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir | Grant | A | 29.47 | 8,370 | 246,664 | 134,710 | 126.3 K to 134.7 K (+6.62 %) |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Sheldrick Robin Cashen | Senior VP, Human Re ... | Option Exercise | A | 29.47 | 628 | 18,507 | 1,277 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Sheldrick Robin Cashen | Senior VP, Human Re ... | Option Exercise | A | 29.47 | 1,254 | 36,955 | 8,669 | |
Mar 06 2008 | SFCC | PharmaNet Developm ... | Sheldrick Robin Cashen | Senior VP, Human Re ... | Grant | A | 29.47 | 3,128 | 92,182 | 17,302 | 14.2 K to 17.3 K (+22.07 %) |
Jan 16 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Option Exercise | M | 38.63 | 15,000 | 579,450 | 0 | |
Jan 16 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Sell | S | 41.84 | 1,600 | 66,944 | 158,409 | 160 K to 158.4 K (-1.00 %) |
Jan 16 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Sell | S | 41.80 | 13,400 | 560,120 | 160,009 | 173.4 K to 160 K (-7.73 %) |
Jan 16 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Buy | M | 38.63 | 15,000 | 579,450 | 173,409 | 158.4 K to 173.4 K (+9.47 %) |
Jan 07 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Option Exercise | M | 4.00 | 22,500 | 90,000 | 15,000 | |
Jan 07 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Option Exercise | M | 4.37 | 22,500 | 98,325 | 37,500 | |
Jan 07 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Option Exercise | M | 10.79 | 22,500 | 242,775 | 60,000 | |
Jan 07 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Option Exercise | M | 11.18 | 45,000 | 503,100 | 82,500 | |
Jan 07 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Buy | M | 4.00 | 22,500 | 90,000 | 158,409 | 135.9 K to 158.4 K (+16.56 %) |
Jan 07 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Buy | M | 4.37 | 22,500 | 98,325 | 135,909 | 113.4 K to 135.9 K (+19.84 %) |
Jan 07 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Buy | M | 10.79 | 22,500 | 242,775 | 113,409 | 90.9 K to 113.4 K (+24.75 %) |
Jan 07 2008 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Buy | M | 11.18 | 45,000 | 503,100 | 90,909 | 45.9 K to 90.9 K (+98.02 %) |
Dec 12 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | Former EVP | Sell | S | 41.41 | 1,000 | 41,409 | 5,766 | 6.8 K to 5.8 K (-14.78 %) |
Dec 12 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | Former EVP | Sell | S | 42.50 | 1,000 | 42,500 | 6,766 | 7.8 K to 6.8 K (-12.88 %) |
Dec 12 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | Former EVP | Sell | S | 42.00 | 1,000 | 42,000 | 7,766 | 8.8 K to 7.8 K (-11.41 %) |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | M | 26.91 | 1,678 | 45,155 | 0 | |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | M | 38.00 | 1,000 | 38,000 | 0 | |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | M | 38.00 | 1,130 | 42,940 | 1,000 | |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 40.85 | 2,678 | 109,398 | 8,766 | 11.4 K to 8.8 K (-23.40 %) |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Buy | M | 26.91 | 1,678 | 45,155 | 11,442 | 9.8 K to 11.4 K (+17.19 %) |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Buy | M | 38.00 | 1,000 | 38,000 | 9,766 | 8.8 K to 9.8 K (+11.41 %) |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 41.40 | 1,000 | 41,400 | 8,766 | 9.8 K to 8.8 K (-10.24 %) |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 41.25 | 1,000 | 41,250 | 9,766 | 10.8 K to 9.8 K (-9.29 %) |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 40.75 | 1,500 | 61,125 | 10,766 | 12.3 K to 10.8 K (-12.23 %) |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 39.75 | 1,000 | 39,750 | 12,266 | 13.3 K to 12.3 K (-7.54 %) |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 40.00 | 1,130 | 45,200 | 13,266 | 14.4 K to 13.3 K (-7.85 %) |
Dec 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Buy | M | 38.00 | 1,130 | 42,940 | 14,396 | 13.3 K to 14.4 K (+8.52 %) |
Dec 05 2007 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Grant | A | 31.60 | 2,472 | 78,115 | 45,909 | 43.4 K to 45.9 K (+5.69 %) |
Dec 05 2007 | SFCC | PharmaNet Developm ... | LUCKING DAVID | Director | Grant | A | 31.60 | 1,648 | 52,077 | 24,023 | 22.4 K to 24 K (+7.37 %) |
Dec 03 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | M | 38.00 | 1,000 | 38,000 | 3,808 | |
Dec 03 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | M | 38.00 | 5,000 | 190,000 | 4,808 | |
Dec 03 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 40.00 | 1,000 | 40,000 | 13,266 | 14.3 K to 13.3 K (-7.01 %) |
Dec 03 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Buy | M | 38.00 | 1,000 | 38,000 | 14,266 | 13.3 K to 14.3 K (+7.54 %) |
Dec 03 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 40.18 | 5,000 | 200,913 | 13,266 | 18.3 K to 13.3 K (-27.37 %) |
Dec 03 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Buy | M | 38.00 | 5,000 | 190,000 | 18,266 | 13.3 K to 18.3 K (+37.69 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | M | 7.03 | 1,500 | 10,545 | 9,808 | |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | M | 24.37 | 750 | 18,278 | 0 | |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 38.75 | 1,515 | 58,706 | 13,909 | 15.4 K to 13.9 K (-9.82 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 38.50 | 1,000 | 38,500 | 15,424 | 16.4 K to 15.4 K (-6.09 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 38.25 | 1,000 | 38,250 | 16,424 | 17.4 K to 16.4 K (-5.74 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 38.00 | 1,000 | 38,000 | 17,424 | 18.4 K to 17.4 K (-5.43 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 37.50 | 1,000 | 37,500 | 18,424 | 19.4 K to 18.4 K (-5.15 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 36.97 | 1,000 | 36,965 | 19,424 | 20.4 K to 19.4 K (-4.90 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 36.75 | 1,000 | 36,750 | 20,424 | 21.4 K to 20.4 K (-4.67 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 37.00 | 1,250 | 46,250 | 21,424 | 22.7 K to 21.4 K (-5.51 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Buy | M | 7.03 | 1,500 | 10,545 | 22,674 | 21.2 K to 22.7 K (+7.08 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Buy | M | 24.37 | 750 | 18,278 | 21,174 | 20.4 K to 21.2 K (+3.67 %) |
Nov 15 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | M | 24.37 | 2,000 | 48,740 | 12,058 | |
Nov 15 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | M | 24.37 | 12,000 | 292,440 | 0 | |
Nov 15 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 36.63 | 2,000 | 73,250 | 18,887 | 20.9 K to 18.9 K (-9.58 %) |
Nov 15 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Buy | M | 24.37 | 2,000 | 48,740 | 20,887 | 18.9 K to 20.9 K (+10.59 %) |
Nov 15 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Sell | S | 35.32 | 12,000 | 423,886 | 18,887 | 30.9 K to 18.9 K (-38.85 %) |
Nov 15 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Buy | M | 24.37 | 12,000 | 292,440 | 30,887 | 18.9 K to 30.9 K (+63.54 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | WOLD OLSEN PER | Director | Buy | P | 37.00 | 3,900 | 144,300 | 12,344 | 8.4 K to 12.3 K (+46.19 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | WOLD OLSEN PER | Director | Buy | P | 36.99 | 100 | 3,699 | 8,444 | 8.3 K to 8.4 K (+1.20 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | WOLD OLSEN PER | Director | Buy | P | 36.95 | 400 | 14,780 | 8,344 | 7.9 K to 8.3 K (+5.04 %) |
Nov 19 2007 | SFCC | PharmaNet Developm ... | WOLD OLSEN PER | Director | Buy | P | 36.93 | 600 | 22,158 | 7,944 | 7.3 K to 7.9 K (+8.17 %) |
Nov 07 2007 | SFCC | PharmaNet Developm ... | LUCKING DAVID | Director | Sell | S | 37.20 | 20,000 | 744,000 | 24,023 | 44 K to 24 K (-45.43 %) |
Oct 03 2007 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Sell | S | 30.34 | 316 | 9,587 | 10,770 | 11.1 K to 10.8 K (-2.85 %) |
Oct 25 2007 | SFCC | PharmaNet Developm ... | TOMBROS PETER G | Director | Grant | A | 34.78 | 1,048 | 36,449 | 9,896 | 8.8 K to 9.9 K (+11.84 %) |
Oct 03 2007 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Sell | S | 30.34 | 540 | 16,384 | 49,370 | 49.9 K to 49.4 K (-1.08 %) |
Aug 07 2007 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir. | Option Exercise | A | 26.91 | 8,609 | 231,668 | 68,609 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir. | Option Exercise | A | 26.91 | 16,155 | 434,731 | 144,548 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | McMullen Jeffrey P | Pres., CEO and Dir. | Grant | A | 26.91 | 8,609 | 231,668 | 129,823 | 121.2 K to 129.8 K (+7.10 %) |
Aug 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | A | 26.91 | 894 | 24,058 | 894 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Option Exercise | A | 26.91 | 1,678 | 45,155 | 26,058 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | NATAN DAVID | EVP | Grant | A | 26.91 | 894 | 24,058 | 18,887 | 18 K to 18.9 K (+4.97 %) |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Option Exercise | A | 26.91 | 3,060 | 82,345 | 3,060 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Option Exercise | A | 26.91 | 5,742 | 154,517 | 33,618 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Newman Thomas Joseph | EVP | Grant | A | 26.91 | 3,060 | 82,345 | 42,301 | 39.2 K to 42.3 K (+7.80 %) |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Boucher-Champagne Johane | EVP | Option Exercise | A | 26.91 | 867 | 23,331 | 867 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Boucher-Champagne Johane | EVP | Option Exercise | A | 26.91 | 1,627 | 43,783 | 39,127 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Boucher-Champagne Johane | EVP | Grant | A | 26.91 | 867 | 23,331 | 12,249 | 11.4 K to 12.2 K (+7.62 %) |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Di Ianni Mark | EVP and Pres, Early ... | Option Exercise | A | 26.91 | 2,477 | 66,656 | 2,477 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Di Ianni Mark | EVP and Pres, Early ... | Option Exercise | A | 26.91 | 4,649 | 125,105 | 4,649 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Di Ianni Mark | EVP and Pres, Early ... | Grant | A | 26.91 | 2,477 | 66,656 | 14,967 | 12.5 K to 15 K (+19.83 %) |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Hamill John P | EVP, CFO, Scty, and ... | Option Exercise | A | 26.91 | 2,415 | 64,988 | 27,415 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Hamill John P | EVP, CFO, Scty, and ... | Option Exercise | A | 26.91 | 4,533 | 121,983 | 8,999 | |
Aug 07 2007 | SFCC | PharmaNet Developm ... | Hamill John P | EVP, CFO, Scty, and ... | Grant | A | 26.91 | 2,415 | 64,988 | 39,470 | 37.1 K to 39.5 K (+6.52 %) |
Jul 05 2007 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Sell | S | 31.78 | 300 | 9,534 | 11,086 | 11.4 K to 11.1 K (-2.63 %) |
Jul 03 2007 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Sell | S | 31.78 | 510 | 16,208 | 49,910 | 50.4 K to 49.9 K (-1.01 %) |
Jun 08 2007 | SFCC | PharmaNet Developm ... | TOMBROS PETER G | Director | Grant | A | 31.60 | 3,955 | 124,978 | 8,848 | 4.9 K to 8.8 K (+80.83 %) |
Jun 08 2007 | SFCC | PharmaNet Developm ... | OLIVIER DAVID M | Director | Grant | A | 31.60 | 3,955 | 124,978 | 7,344 | 3.4 K to 7.3 K (+116.70 %) |
Jun 08 2007 | SFCC | PharmaNet Developm ... | CLASSON ROLF A | Director | Grant | A | 31.60 | 3,955 | 124,978 | 8,848 | 4.9 K to 8.8 K (+80.83 %) |
Jun 08 2007 | SFCC | PharmaNet Developm ... | WOLD OLSEN PER | Director | Grant | A | 31.60 | 3,955 | 124,978 | 7,344 | 3.4 K to 7.3 K (+116.70 %) |
Jun 08 2007 | SFCC | PharmaNet Developm ... | Elias Lewis R | Director | Grant | A | 31.60 | 3,955 | 124,978 | 11,386 | 7.4 K to 11.4 K (+53.22 %) |
Jun 08 2007 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Grant | A | 31.60 | 5,933 | 187,483 | 50,420 | 44.5 K to 50.4 K (+13.34 %) |
Jun 08 2007 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Grant | A | 31.60 | 3,955 | 124,978 | 18,317 | 14.4 K to 18.3 K (+27.54 %) |
Jun 08 2007 | SFCC | PharmaNet Developm ... | LUCKING DAVID | Director | Grant | A | 31.60 | 3,955 | 124,978 | 46,330 | 42.4 K to 46.3 K (+9.33 %) |
May 08 2007 | SFCC | PharmaNet Developm ... | LEBEL MARC | See Remarks | Sell | S | 32.91 | 22,426 | 738,040 | 0 | 22.4 K to 0 (-100.00 %) |
Apr 05 2007 | SFCC | PharmaNet Developm ... | LEVINE JACK | Director | Sell | S | 26.10 | 625 | 16,313 | 44,487 | 45.1 K to 44.5 K (-1.39 %) |
Apr 05 2007 | SFCC | PharmaNet Developm ... | Golieb Arnold | Director | Sell | S | 26.10 | 850 | 22,185 | 15,310 | 16.2 K to 15.3 K (-5.26 %) |
Apr 05 2007 | SFCC | PharmaNet Developm ... | LUCKING DAVID | Director | Sell | S | 26.10 | 735 | 19,184 | 42,375 | 43.1 K to 42.4 K (-1.70 %) |